Skip to main content
Clinical Trials/NCT06922370
NCT06922370RecruitingNot Applicable

The Osteoarticular Manifestations in Patients With Gitelman Syndrome

Second Affiliated Hospital, School of Medicine, Zhejiang University1 site in 1 country120 target enrollmentStarted: November 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
120
Locations
1
Primary Endpoint
The presence of chondrocalcinosis

Study Overview

Brief Summary

Patients with clinically and genetically confirmed Gitelman Syndrome are screened for CPPD, and the clinical and radiographic manifestations are collected and analyzed.

Detailed Description

Patients with clinically and genetically confirmed Gitelman Syndrome are screened for calcium pyrophosphate deposition, and the clinical data and radiographic manifestations are collected and analyzed to investigate the osteoarticular features in patients with Gitelman Syndrome.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients confirmed with Gitelman Syndrome

Exclusion Criteria

  • •Patients with other confounding situations such as Bartter Syndrome, hyperparathyroidism

Outcomes

Primary Outcomes

The presence of chondrocalcinosis

Time Frame: From the enrollment to the performance of the CPPD screen

The presence of chondrocalcinosis on conventional radiograph or computed tomography in patients with Gitelman Syndrome

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials